Perrigo Receives Binding Offer to Divest Its Hra Pharma Rare Diseases Business for up to €275 Million
Perrigo收到具有约束力的要约,将以高达2.75亿欧元的价格剥离其Hra Pharma罕见病业务
Perrigo Receives Binding Offer to Divest Its Hra Pharma Rare Diseases Business for up to €275 Million
Perrigo收到具有约束力的要约,将以高达2.75亿欧元的价格剥离其Hra Pharma罕见病业务
使用浏览器的分享功能,分享给你的好友吧